These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6686565)

  • 1. [Thrombolytic properties of longolytin--a complex of enzymes isolated from an Arthrobothrys longa culture].
    Andreenko GV; Serebriakova TN; Tsymanovich SG; Maksimov RA; Sharkova TS
    Gematol Transfuziol; 1983 Dec; 28(12):48-50. PubMed ID: 6686565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic and fibrinolytic action of tricholysin].
    Gavrilov OK; Andreenko GV; Silaev AB; Serebriakova TN; Maksimova RA
    Probl Gematol Pereliv Krovi; 1979 Feb; 24(2):15-9. PubMed ID: 424397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic action of a heparin-ocrase complex].
    Liapina LA; Klöcking HP
    Farmakol Toksikol; 1978; 41(2):174-7. PubMed ID: 658360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinolytic and thrombolytic effect of proteases from various fungal cultures].
    Andreenko GW; Silaev AB; Maksimova RA; Poch LI; Serebrjakova TN
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):14-21. PubMed ID: 4134256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of tricholysine on plasma fibrinolytic activity].
    Serebriakova TN; Andreenko GV; Maksimova RA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (8):46-51. PubMed ID: 7196773
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development and production of a triase fibrinolytic preparation].
    Gavrilov OK; Murashova NS; Kozlova MA; Sirotenko AV; Subbotina LA
    Gematol Transfuziol; 1985 Aug; 30(8):51-6. PubMed ID: 3902558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis].
    Kalishevskaia TM; Golubeva MG; Bashkov GV; Vinter VB
    Fiziol Zh (1978); 1988; 34(3):88-93. PubMed ID: 2842201
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental thrombosis in rabbit marginal ear vein and evaluation of the thrombolytic action of longolytin.
    Podorol'skaya LV; Serebryakova TN; Sharkova TS; Neumyvakin LV; Khromov IS; Khokhlov NV; Tarantul VZ
    Bull Exp Biol Med; 2007 May; 143(5):577-80. PubMed ID: 18239771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of a column chromatographic method for obtaining a thrombolytic preparation from the culture broth of the fungus Trichothecium roseum].
    Gavrilov OK; Murashova NS; Ivanova IV; Kozlova MA; Sirotenko AV
    Gematol Transfuziol; 1985 Jan; 30(1):56-8. PubMed ID: 3884435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic complexes of low-molecular heparin and acetylsalicylic acid].
    Kudriashov BA; Pastorova VE; Liapina LA; Kondashevskaia MV
    Biull Eksp Biol Med; 1992 Jul; 114(8):141-3. PubMed ID: 1334726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity.
    Barzkar N; Jahromi ST; Vianello F
    Mar Drugs; 2022 Jan; 20(1):. PubMed ID: 35049901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New thrombolytic drugs].
    Ferstrate M
    Kardiologiia; 1990 Feb; 30(2):120-6. PubMed ID: 2190038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental thrombolysis].
    Shumakov VI; Chepurov AK
    Kardiologiia; 1972 Feb; 12(2):88-91. PubMed ID: 4264094
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological basis of thrombolytic therapy].
    Kleking GP; Bokarev IN
    Klin Med (Mosk); 1990 Jun; 68(6):13-9. PubMed ID: 2214624
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbial fibrinolytic enzymes: an overview of source, production, properties, and thrombolytic activity in vivo.
    Peng Y; Yang X; Zhang Y
    Appl Microbiol Biotechnol; 2005 Nov; 69(2):126-32. PubMed ID: 16211381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents].
    Kalishevskaia TM; Golubeva MG; Bashkov GV
    Patol Fiziol Eksp Ter; 1988; (3):24-8. PubMed ID: 2902551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Round table discussion on current problems in thrombolytic therapy].
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):489-96. PubMed ID: 63438
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.